基于栖息地分析的瘤内异质性定量用于结直肠癌淋巴血管侵犯术前评估
本研究回顾性纳入177例结直肠癌患者的治疗前18F-FDG PET/CT图像,提取常规影像组学特征和栖息地分析衍生的肿瘤异质性特征,构建四种淋巴血管侵犯分类模型。验证队列中,瘤内异质性评分模型AUC为0.712,优于影像组学评分模型(AUC 0.650)和临床模型(AUC 0.652);联合模型训练集和验证集AUC分别为0.857和0.798,校准图拟合良好(P>0.05)。
要点
- 治疗前18F-FDG PET/CT的栖息地分析衍生瘤内异质性评分可用于术前评估结直肠癌淋巴血管侵犯风险。
- 验证队列中瘤内异质性评分模型AUC(0.712)优于影像组学评分模型(0.650)和临床模型(0.652)。
- 联合临床变量、瘤内异质性评分和影像组学评分的联合模型分类效果更佳,训练集AUC 0.857、验证集AUC 0.798。
核心结论
- 瘤内异质性评分是一种新颖且稳定的淋巴血管侵犯定量指标,整合临床变量和影像组学特征后有助于有效进行结直肠癌患者淋巴血管侵犯风险分层。
研究设计与样本
- 回顾性研究,纳入177例诊断为结直肠癌的患者,训练队列n=106、验证队列n=71,采集治疗前18F-FDG PET/CT图像,提取常规影像组学特征和栖息地分析衍生的肿瘤异质性特征。
关键影像表现/征象
- 从18F-FDG PET图像提取常规影像组学特征和栖息地衍生的肿瘤异质性特征。
- 基于影像的随机森林模型输出概率分别生成影像组学评分(Radscore)和瘤内异质性评分(ITHscore)。
诊断标准与关键数值
- 多因素logistic回归分析保留PET/CT报告的淋巴结状态、ITHscore和Radscore作为结直肠癌患者淋巴血管侵犯风险的预测因子(P<0.05)。
- 验证队列中ITHscore模型AUC为0.712,优于Radscore模型(AUC 0.650)和临床模型(AUC 0.652)。
- 联合模型在训练队列和验证队列的AUC分别为0.857和0.798。
- 联合模型列线图的校准图拟合良好(P>0.05)。
- Spearman秩相关检验显示ITHscore与Radscore无显著相关性(训练队列R=0.044,P=0.655;验证队列R=0.067,P=0.580)。
临床应用与阅片要点
- 作者认为ITHscore是一种新颖且稳定的淋巴血管侵犯定量指标,整合临床变量和影像组学特征后有助于有效进行结直肠癌患者淋巴血管侵犯风险分层。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
RATIONALE AND OBJECTIVES: Preoperative knowledge of the status of lymphovascular invasion (LVI) status in colorectal cancer (CRC) patients can provide valuable information for choosing appropriate treatment strategies. This study aimed to explore the value of heterogeneity features derived from the habitat analysis of 18F-fluorodeoxyglucose (FDG) positron emission tomography (PET) images in predicting LVI.
MATERIALS AND METHODS: Pretreatment 18F-FDG PET/computed tomography (CT) images from 177 patients diagnosed with CRC were retrospectively obtained (training cohort, n=106; validation cohort, n=71). Conventional radiomics features and habitat-derived tumor heterogeneity features were extracted from 18F-FDG PET scans. The output probabilities of the imaging-based random forest model were used to generate a radiomics score (Radscore) and intratumoral heterogeneity score (ITHscore). Multivariate logistic regression analysis was used to determine the independent risk factors for LVI. On this basis, four LVI status classification models were developed using (a) clinical variables (Clinical model), (b) tumor heterogeneity features (ITHscore model), (c) radiomics features (Radscore model), and (d) clinical variables, tumor heterogeneity features, and radiomics features (Combined model). The area under the curve (AUC) and decision curve analysis were used to evaluate model performance.
RESULTS: Among all of the variables, the PET/CT-reported lymph node status, ITHscore, and Radscore were retained as predictors related to the risk of LVI in CRC patients (P<0.05). The predictive effect of the ITHscore model (AUC: 0.712) was better than that of the Radscore model (AUC: 0.650) and Clinical model (AUC: 0.652) in the validation cohort. The Combined model achieved better classification effects and clinical usefulness, and the AUCs of the training and validation cohorts were 0.857 and 0.798, respectively. A nomogram of the Combined model was established, and the calibration plot was well fitted (P>0.05). In addition, the results of Spearman's rank correlation tests showed that there was no significant correlation between the ITHscore and Radscore (R=0.044, P=0.655 in the training cohort; R=0.067, P=0.580 in the validation cohort).
CONCLUSION: Our results showed that the ITHscore is a novel and stable quantitative indicator of LVI and is helpful for effectively facilitating the risk stratification of LVI in CRC patients after integrating clinical variables and radiomics features.
引用
- Su Y, Zhao H, Lyu Z, et al. Quantification of Intratumoral Heterogeneity Based on Habitat Analysis for Preoperative Assessment of Lymphovascular Invasion in Colorectal Cancer. Acad Radiol. 2025. PMID: 40175205. doi:10.1016/j.acra.2025.03.014
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。